![](/img/cover-not-exists.png)
An open-label phase 1 clinical trial of the anti-α 4 β 7 monoclonal antibody vedolizumab in HIV-infected individuals
Sneller, Michael C., Clarridge, Katherine E., Seamon, Catherine, Shi, Victoria, Zorawski, Marek D., Justement, Jesse Shawn, Blazkova, Jana, Huiting, Erin D., Proschan, Michael A., Mora, Jorge Rodrigo,Language:
english
Journal:
Science Translational Medicine
DOI:
10.1126/scitranslmed.aax3447
Date:
September, 2019
File:
PDF, 567 KB
english, 2019